Litcius/Paper detail

Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?

Adriano José Maia Chaves Filho, Franciane Gonçalves, Melina Mottin, Carolina Horta Andrade, Sílvia Nunes Szente Fonseca, Danielle S. Macêdo

2021Journal of Neuroimmune Pharmacology24 citationsDOIOpen Access PDF

Topics & Concepts

NeuroinflammationRepurposingDrug repositioningMinocyclineMedicineNeuroprotectionDoxycyclineProinflammatory cytokineImmunologyMicrogliaPneumoniaPharmacologyInflammationBiologyDrugAntibioticsInternal medicineMicrobiologyEcologyLong-Term Effects of COVID-19Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? | Litcius